TRIMEFI

Indicated in the treatment of diseases of bacterial origin in equines, ovines, swines and equines. In general for the treatment of infectious processes caused by pathogenic germs sensitive to the association such as: Escherichia coli, Haemophilus sp., Fusobacterium sp., Pasteurella sp., Shigella sp., Actinobacillus sp., Actinomyces sp., Aerobacter sp., Staphylococcus sp., Streptococcus sp., Corynebacterium sp., Campylobacter sp., Klebsiella sp., Bordetella sp.

Guaranteed composition:

Each mL of suspension for injection contains:

• Sulfadiazine sodium 400 mg
  (Equivalent to 367,7 mg sulfadiazine base)
• Trimethoprim Micronized 80 mg
• Excipients c.s.p. 1 mL

Species for which it is recommended:

Bovines, ovines, swines and equines.

Route of administration:

It should be used intramuscularly exclusively.

Dosage:

1 mL of TRIMEFI per 30 kg of body weight daily for 3 to 5 days.

Withdrawal time:

• Treated animals should not be sacrificed for human consumption until 10 days after the end of treatment.
• The milk produced during the treatment and up to 72 hours after the end of it, should not be given for human consumption.

Cautions:

• Do not apply intravenously.
• Individual hypersensitivity to the components of the product.
• Keep at a temperature below 30 °C.
• Shake the product before using.

Presentations:

Bottle of 1o, 20, 50, 100, and 250 mL.

ICA Reg. No.: 7940-MV